fig2

 <i>In silico</i> analysis of LGR6 as a tumor suppressor in prostate cancer

Figure 2. Survival and clinical correlation analysis of prognosis-associated GPCR genes. (A) Box plots showing differential expression of the 7 prognosis-associated genes, with blue and orange boxes indicating normal and case groups, respectively. (B) Disease-free survival (DFS) analysis of OR51E2, with green and red curves representing low and high expression groups, respectively. (C) DFS analysis of LGR6. (D and E) Clinical correlation analyses of LGR6 (D) and OR51E2 (E), including associations with Gleason score, T stage, and N stage.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/